tag:blogger.com,1999:blog-2741672436160438708.post7122005094081951269..comments2024-03-26T12:50:32.070-07:00Comments on Learning from and about cancer (chronic lymphocytic leukemia or CLL) by Dr. Brian Koffman: ASH 2013: Dr. Adrian Wiestner Discusses Prognostic and Predictive Factors, the Nuances of 17p deletion and Residual DiseaseBrian Koffmanhttp://www.blogger.com/profile/13250684684103918493noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-2741672436160438708.post-54525587330899864192013-12-27T09:08:59.003-08:002013-12-27T09:08:59.003-08:00This discussion is fascinating and subtle. Thanks ...This discussion is fascinating and subtle. Thanks for enhancing my understanding of treatment with kinase inhibitors.Anonymoushttps://www.blogger.com/profile/02863619510016829657noreply@blogger.comtag:blogger.com,1999:blog-2741672436160438708.post-64630763853256996082013-12-26T15:10:14.701-08:002013-12-26T15:10:14.701-08:00Great stuff again Brian. Trying to read between t...Great stuff again Brian. Trying to read between the lines and figure out whether he believes as you said that kinase inhibitors--by allowing such significant disease to stay in blood--will ultimately be harbingers of mutations and harder to treat disease if used long enough.<br /><br />My only other gnawing question is, is that beer in your glass and if so, what kind?!Anonymousnoreply@blogger.com